BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34159474)

  • 1. Early reflector localization improves the accuracy of localization and excision of a previously positive axillary lymph node following neoadjuvant chemotherapy in patients with breast cancer.
    Balija TM; Braz D; Hyman S; Montgomery LL
    Breast Cancer Res Treat; 2021 Aug; 189(1):121-130. PubMed ID: 34159474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Targeted Axillary Dissection With Radar Reflector Localization Before Neoadjuvant Chemotherapy.
    Coogan AC; Lunt LG; O'Donoghue C; Keshwani SS; Madrigrano A
    J Surg Res; 2024 Mar; 295():597-602. PubMed ID: 38096773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study.
    Baker JL; Haji F; Kusske AM; Fischer CP; Hoyt AC; Thompson CK; Lee MK; Attai D; DiNome ML
    Breast Cancer Res Treat; 2022 Jan; 191(1):107-114. PubMed ID: 34652548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radar reflector guided axillary surgery in node positive breast cancer patients.
    Feinberg JA; Axelrod D; Guth A; Maldonado L; Darvishian F; Pourkey N; Goodgal J; Schnabel F
    Expert Rev Med Devices; 2022 Oct; 19(10):791-795. PubMed ID: 36345879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection.
    Weinfurtner RJ; Leon A; Calvert A; Lee MC
    Clin Imaging; 2022 Oct; 90():19-25. PubMed ID: 35908456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer.
    Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR
    Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes.
    Plecha D; Bai S; Patterson H; Thompson C; Shenk R
    Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediary clip placement to assist accurate axillary lymph node localization.
    Price ER; Vyas S; Lee AY; Wong JM; Joe BN; Ray KM
    Clin Imaging; 2021 May; 73():96-100. PubMed ID: 33352497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers.
    Laws A; Dillon K; Kelly BN; Kantor O; Hughes KS; Gadd MA; Smith BL; Lamb LR; Specht M
    Ann Surg Oncol; 2020 Nov; 27(12):4819-4827. PubMed ID: 32740737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol.
    van Loevezijn AA; van der Noordaa MEM; Stokkel MPM; van Werkhoven ED; Groen EJ; Loo CE; Elkhuizen PHM; Sonke GS; Russell NS; van Duijnhoven FH; Vrancken Peeters MTFD
    Breast Cancer Res Treat; 2022 May; 193(1):37-48. PubMed ID: 35239072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer.
    Has Simsek D; Emiroglu S; Yilmaz R; Bayram A; Isik EG; Tukenmez M; Kuyumcu S; Dursun M; Muslumanoglu M; Cabioglu N
    Clin Nucl Med; 2022 Nov; 47(11):e682-e688. PubMed ID: 35835147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study.
    García-Novoa A; Acea-Nebril B; Díaz Carballada C; Bouzón Alejandro A; Conde C; Cereijo Garea C; Varela JR; Santiago Freijanes P; Antolín Novoa S; Calvo Martínez L; Díaz I; Rodríguez Martínez S; Mosquera Oses J
    Ann Surg Oncol; 2021 Feb; 28(2):958-967. PubMed ID: 32725521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Axillary Evaluation Using Reflector-Guided Sentinel Lymph Node Biopsy: A Prospective Feasibility Study and Comparison With Conventional Lymphatic Mapping Techniques.
    Taback B; Jadeja P; Ha R
    Clin Breast Cancer; 2018 Oct; 18(5):e869-e874. PubMed ID: 29544701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted axillary dissection using Radioguided Occult Lesion Localization technique in the clinically negative marked lymph node after neoadjuvant treatment in breast cancer patients.
    Del Castillo A; Gomez-Modet S; Mata JM; Tejedor L
    Eur J Surg Oncol; 2023 Jul; 49(7):1184-1188. PubMed ID: 36958951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization.
    Sun J; Henry DA; Carr MJ; Yazdankhahkenary A; Laronga C; Lee MC; Hoover SJ; Sun W; Czerniecki BJ; Khakpour N; Kiluk JV
    Clin Breast Cancer; 2021 Jun; 21(3):e189-e193. PubMed ID: 32893094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center.
    Sargent RE; Siegel E; Ito F; Kramme K; Kraft E; Hendrix V; Carr AA; Nelson ME; Bian SX; Jayachandran P; Sener SF
    J Surg Oncol; 2023 Jul; 128(1):9-15. PubMed ID: 36933187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study.
    Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI
    World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement.
    de Wild SR; Koppert LB; van Nijnatten TJA; Kooreman LFS; Vrancken Peeters MTFD; Smidt ML; Simons JM
    Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38531689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
    Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
    Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.